All news

The collaboration focuses on optimising long-acting compounds

24 February 2014

Send us your active compound structures and ideas to help catalyse neglected disease drug discovery

18 February 2014

A significant milestone reached in partnership with MMV

06 February 2014

Combined R&D expertise will focus on two antimalarial compounds

24 December 2013

US FDA grants expedited approval status for tafenoquine

20 December 2013

Study results published today in The Lancet

19 December 2013

The new laboratory, supported by MMV and the UK government, is set to boost research capacity in the region

10 December 2013

Report hails recent progress but warns new tools are needed 

10 December 2013

Compounds that hit the target may be capable of curing, preventing and blocking the transmission of malaria

29 November 2013

MMV, DNDi and RSC sign MoU to foster a global community of open source drug discovery researchers

27 November 2013